Xeris Biopharma Holdings, Inc. (XERS) stock
XERSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.99+0.19 (+1.13%)
Close on Nov 18, 2026Market cap $3.10BP/E –Yield –
Xeris Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Xeris Biopharma's price to book ratio was 107.2× on Jul 31, 2026, against 11.9× a year earlier. Over the last 3 years it ranged from 1.4× to 107.2×, with a median of 6.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 107.2× | +19.3 |
| 2024 | Jan 31, 2024 | 87.9× | +3.9 |
| 2023 | Dec 29, 2023 | 83.9× | +80.7 |
| 2022 | Dec 30, 2022 | 3.3× | +0.0 |
| 2021 | Oct 29, 2021 | 3.3× | – |
See a number that looks wrong?